Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -228.54M
March 31, 2026 -225.08M
December 31, 2025 -233.07M
September 30, 2025 -274.52M
June 30, 2025 -284.02M
March 31, 2025 -317.01M
December 31, 2024 -274.94M
September 30, 2024 -274.36M
June 30, 2024 -299.26M
March 31, 2024 -300.71M
December 31, 2023 -345.46M
September 30, 2023 -363.41M
June 30, 2023 -383.13M
March 31, 2023 -417.57M
December 31, 2022 -386.92M
Date Value
September 30, 2022 -387.79M
June 30, 2022 -363.20M
March 31, 2022 -309.49M
December 31, 2021 -284.05M
September 30, 2021 -248.94M
June 30, 2021 -191.49M
March 31, 2021 -143.10M
December 31, 2020 -157.99M
September 30, 2020 -128.91M
June 30, 2020 -118.17M
March 31, 2020 -102.18M
December 31, 2019 -68.42M
September 30, 2019 -60.46M
June 30, 2019 -81.32M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Natera, Inc. 51.20M
Quest Diagnostics, Inc. 1.349B
Labcorp Holdings, Inc. 1.155B
OPKO Health, Inc. -134.02M
Psychemedics Corp. --